U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07526987) titled 'Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis' on April 08.
Brief Summary: The aim of this study is to assess the efficacy and safety of minocycline in improving functional outcome among patients with acute ischaemic stroke receiving intravenous thrombolysis.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Ischaemic Stroke
Intervention:
DRUG: Minocycline Hydrochloride Capsule (50 mg per capsule)
A loading dose of 200 mg will be administered before intravenous thrombolysis or within 2 hours after the initiation of intravenous thrombolysis, followed...